Beginning with a moderately potent PPARgamma agonist 9, a series of potent and highly subtype-selective PPARalpha agonists was identified through a systematic SAR study. Based on the results of the efficacy studies in the hamster and dog models of dyslipidemia and the desired pharmacokinetic data, the optimized compound 39 was selected for further profiling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2005.12.022 | DOI Listing |
Publication Analysis
Top Keywords
subtype-selective pparalpha
8
pparalpha agonists
8
design synthesis
4
synthesis potent
4
potent subtype-selective
4
agonists moderately
4
moderately potent
4
potent ppargamma
4
ppargamma agonist
4
agonist series
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!